These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24767701)

  • 1. Renal cell carcinoma treated with stereotactic radiotherapy with histological change confirmed on autopsy: a case report.
    Onishi H; Kawasaki T; Zakoji H; Yoshida T; Komiyama T; Kuriyama K; Araya M; Saito R; Aoki S; Maehata Y; Tominaga L; Marino K; Watanabe I; Oguri M; Araki T; Enomoto N; Takeda M; Katoh R
    BMC Res Notes; 2014 Apr; 7():270. PubMed ID: 24767701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated postoperative irradiation in localized renal cell cancer: A case report and pertinent literature review.
    Zhao XR; Shan GL; Zhang Y; Yu YH
    J Cancer Res Ther; 2018; 14(Supplement):S260-S262. PubMed ID: 29578185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Cancer is Not Radioresistant: Slowly but Continuing Shrinkage of the Tumor After Stereotactic Body Radiation Therapy.
    Funayama S; Onishi H; Kuriyama K; Komiyama T; Marino K; Araya M; Saito R; Aoki S; Maehata Y; Nonaka H; Tominaga L; Muramatsu J; Nakagomi H; Kamiyama M; Takeda M
    Technol Cancer Res Treat; 2019 Jan; 18():1533033818822329. PubMed ID: 30803362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery.
    Teh BS; Bloch C; Paulino AC; Shen S; Hinckley L; Baskin D; Butler EB; Amato R
    Clin Genitourin Cancer; 2007 Jun; 5(5):334-7. PubMed ID: 17645831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic expanding hematoma of the left erector spinae muscle after stereotactic body radiotherapy for renal cell carcinoma: a case report.
    Ishikawa Y; Yamamoto T; Umezawa R; Takahashi N; Takeda K; Suzuki Y; Jingu K
    J Med Case Rep; 2022 Oct; 16(1):353. PubMed ID: 36184609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma.
    Ponsky L; Lo SS; Zhang Y; Schluchter M; Liu Y; Patel R; Abouassaly R; Welford S; Gulani V; Haaga JR; Machtay M; Ellis RJ
    Radiother Oncol; 2015 Oct; 117(1):183-7. PubMed ID: 26362723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage robot-assisted partial nephrectomy for the management of renal cell carcinoma following failed stereotactic radiotherapy.
    Gorin MA; Gorbatiy V; Glenn C; Shirodkar SP; Castle SM; Jorda M; Leveillee RJ
    JSLS; 2012; 16(1):159-62. PubMed ID: 22906347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-Effect Relationship of Kidney Function After SABR for Primary Renal Cell Carcinoma: TROG 15.03 FASTRACK II.
    Gaudreault M; Hardcastle N; Jackson P; McIntosh L; Higgs B; Pryor D; Sidhom M; Dykyj R; Moore A; Kron T; Siva S
    Int J Radiat Oncol Biol Phys; 2024 Nov; 120(3):648-654. PubMed ID: 38679212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.
    Ranck MC; Golden DW; Corbin KS; Hasselle MD; Liauw SL; Stadler WM; Hahn OM; Weichselbaum RR; Salama JK
    Am J Clin Oncol; 2013 Dec; 36(6):589-95. PubMed ID: 22868242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials.
    Ghia AJ; Chang EL; Bishop AJ; Pan HY; Boehling NS; Amini B; Allen PK; Li J; Rhines LD; Tannir NM; Tatsui CE; Brown PD; Yang JN
    J Neurosurg Spine; 2016 May; 24(5):829-36. PubMed ID: 26799117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 68Ga-PSMA PET/CT to Distinguish Brain Metastasis of Renal Cell Carcinoma From Radiation Necrosis After Stereotactic Radiosurgery.
    Filizoglu N; Cetin IA; Kissa TN; Niftaliyeva K; Ones T
    Clin Nucl Med; 2021 Nov; 46(11):913-914. PubMed ID: 34284481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney.
    Svedman C; Karlsson K; Rutkowska E; Sandström P; Blomgren H; Lax I; Wersäll P
    Acta Oncol; 2008; 47(8):1578-83. PubMed ID: 18607859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney).
    Siva S; Ali M; Correa RJM; Muacevic A; Ponsky L; Ellis RJ; Lo SS; Onishi H; Swaminath A; McLaughlin M; Morgan SC; Cury FL; Teh BS; Mahadevan A; Kaplan ID; Chu W; Grubb W; Hannan R; Staehler M; Warner A; Louie AV
    Lancet Oncol; 2022 Dec; 23(12):1508-1516. PubMed ID: 36400098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation Therapy.
    Miccio J; Johung K
    Oncology (Williston Park); 2019 May; 33(5):167-73, 177. PubMed ID: 31095714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic ablative body radiation therapy for primary kidney cancer: a 3-dimensional conformal technique associated with low rates of early toxicity.
    Pham D; Thompson A; Kron T; Foroudi F; Kolsky MS; Devereux T; Lim A; Siva S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1061-8. PubMed ID: 25442039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic gamma-ray body radiation therapy for asynchronous bilateral renal cell carcinoma.
    Wang YJ; Han TT; Xue JX; Chang DS; Li HQ; Li P; Wang JD; Wang YJ; Xia TY
    Radiol Med; 2014 Nov; 119(11):878-83. PubMed ID: 24696288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal radiosurgery: initial clinical experience with histological evaluation.
    Ponsky LE; Mahadevan A; Gill IS; Djemil T; Novick AC
    Surg Innov; 2007 Dec; 14(4):265-9. PubMed ID: 18178914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic metastases from renal cell carcinoma treated with stereotactic body radiation therapy.
    Bourlon MT; Amini A; Kavanagh BD; Flaig TW
    Oncology (Williston Park); 2014 Nov; 28(11):1008-12. PubMed ID: 25560737
    [No Abstract]   [Full Text] [Related]  

  • 19. Stereotactic Body Radiotherapy for a Rare Case of Sinonasal Metastasis Arising from Renal Cell Cancer.
    Cuccia F; Pastorello E; Vitale C; Figlia V; Levra NG; Mazzola R; Nicosia L; Ricchetti F; Rigo M; Ruggieri R; Alongi F
    In Vivo; 2023; 37(1):490-492. PubMed ID: 36593020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiotherapy for inoperable patients with renal carcinoma.
    Kotzki L; Udrescu C; Lapierre A; Badet L; Rouviere O; Paparel P; Chapet O
    Fr J Urol; 2024 Mar; 34(2):102575. PubMed ID: 38364353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.